LOGIN   |   TRADE NOW   |    LEARN TO TRADE    |   FRANCHISEE   |   REGISTER   |   CONTACT US
Refer A Friend | NRI | Chat | Demo | Careers
What's New? | Feedback | Need Help?
SENSEX
 -
 
 
 
NIFTY
 -
 
 
 
Website Feedback Visit Old Sharekhan Site
Quotes
NAV
News
Comp Info
Earnings


Name:
Mobile:
Email:
Pin:
Only on AMC Accounts (Charges fully adjustable on brokerage).
HOME / MARKET TODAY / COMMODITIES / NEWS STORY

Cabinet okays amendments to HIV and AIDS Bill, 2014
05 Oct 2016
The Cabinet on Wednesday has given its concent to introduce official amendments to the HIV and AIDS (Prevention and Control) Bill, 2014 to safeguard rights of HIV-affected people, to prevent & control spread of HIV and AIDS.

An official statement said that, “The Union Cabinet under the Chairmanship of Prime Minister Narendra Modi has given its approval to introduce official amendments to the HIV and AIDS (Prevention and Control) Bill, 2014.”

Also, the provisions of the Bill seek to address HIV-related discrimination, strengthen the existing programme by bringing in legal accountability and establish formal mechanisms for inquiring into complaints and redressing grievances, the government release added.

Moreover, the Bill seeks to prevent and control the spread of HIV and AIDS, prohibits discrimination against persons with HIV and AIDS, provides for informed consent and confidentiality with regard to their treatment, places obligations on establishments to safeguard rights of persons living with HIV arid create mechanisms for redressing complaints.

The Bill lists various grounds on which discrimination against HIV positive persons and those living with them is prohibited, it said.

These include the denial, termination, discontinuation or unfair treatment with regard to employment, educational establishments, health care services, residing or renting property, standing for public or private office, and provision of insurance (unless based on actuarial studies). The requirement for HIV testing as a pre-requisite for obtaining employment or accessing health care or education is also prohibited.

GET QUOTE
Name of the commodity



USD
68.03 

EUR
72.65 

GBP
86.29 

AED
18.48 

AUD
50.71 

BHD
180.51 

CAD
51.21 

CHF
67.39 

CNY
9.89 

DEM
39.61 

DKK
9.76 

FRF
11.81 

HKD
8.78 

IQD
0.06 

ITL
0.04 

JPY
0.60 

KWD
223.06 

OMR
176.41 

PKR
0.65 

QAR
18.68 

SAR
18.14 

SEK
7.40 

SGD
47.90 

ZAR
4.92 

  • Quick Quote
 
PRIVACY  |  POLICIES  |  ANTI MONEY LAUNDERING POLICY  |  SECURITY  |  DISCLAIMER  |   RESEARCH - DISCLAIMER  |   COPYRIGHT  |  TERMS & CONDITIONS  | 
 CAREERS  |   IMPORTANT LINKS  |   FEEDBACK  |   KYC document in vernacular languages


Registered Office: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai – 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos.: BSE: INB/INF011073351 / BSE-CD ; NSE: INB/INF/INE231073330 ; MSEI: INB/INF261073333 / INE261073330 ;
DP: NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ;
Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com

Sharekhan Financial Services Pvt. Ltd: Registered with IRDA as a Corporate Agent (Life) - Registration No: CA0126

Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do’s & Don’ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing.

Company Identification Number (CIN): Sharekhan Ltd: U99999MH1995PLC087498; Sharekhan Commodities Pvt Ltd: U67120MH2000PTC127261; Sharekhan Financial Services Pvt Ltd: U65920MH2004PTC149518; Sharekhan.Com India Pvt Ltd: U80904MH2000PTC126954; Sharekhan Insurance Broking Ltd: U67120MH2000PLC127257